Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

New study offers suggestions for keeping classrooms safe during the Covid-19 pandemic

Open windows and a good heating, ventilation, and air conditioning (HVAC) system are starting points for keeping classrooms safe during the Covid-19 pandemic. But they are not the last word, according to a new study from researchers at MIT.

11 Aug 2021

COVID-19 risks likely to shift from older adults to younger children

Within the next few years, as the SARS-CoV-2 virus becomes endemic in the global population, COVID-19 may behave like other common-cold coronaviruses, affecting mostly young children who have not yet been vaccinated or exposed to the virus, according to new modeling results.

11 Aug 2021

Breakthrough SARS-CoV-2 infections in patients with systemic rheumatic diseases

A recent study discusses the clinical characteristics and outcomes of patients with SARDs who were previously vaccinated against SARS-CoV-2.

11 Aug 2021

Socioeconomic privilege and political ideology correlate to racial disparities in COVID-19 vaccination

Income, educational attainment, and political ideology all play into racial disparities in vaccination rates that have left African Americans more vulnerable to COVID-19, finds new research from the Center for Health Information and Decision Systems at the University of Maryland's Robert H. Smith School of Business.

11 Aug 2021

UC San Diego’s wastewater surveillance system enables early detection of most COVID-19 cases

People infected with SARS-CoV-2, the virus that causes COVID-19, are known to shed it in their stool, even if they aren't experiencing any symptoms.

11 Aug 2021

Researchers employ artificial intelligence models for image-based detection of COVID-19

Medical imaging has long been a vital tool for the diagnosis and prognostic assessments of many diseases. In recent years, the use of artificial intelligence models has been used in conjunction with this imaging to augment their diagnostic capabilities.

11 Aug 2021

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Scientists from Germany and Belgium have recently described the immunogenicity of a plant-based virus-like particle vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vaccine induces robust antibody and T cell responses for at least 6 months. Moreover, the vaccine demonstrates potent neutralizing efficacy against the B.1.1.7, B.1.351, and P1 variants of SARS-CoV-2.

11 Aug 2021

Both mRNA vaccines protect against symptomatic disease with SARS-CoV-2 Delta variant

A new study demonstrates that the two mRNA vaccines have widely varying efficacies against the SARS-CoV-2 Delta variant.

10 Aug 2021

High alcohol consumption increases risk of SARS-CoV-2 infection, finds US student study

A new study finds that heavy alcohol drinking is associated with an increase in the number of COVID-19 cases among American college students.

10 Aug 2021

Natural vs. vaccine-induced COVID-19 immunity

A new paper discusses the protection offered by immunity against COVID-19 following vaccination as compared to natural infection.

10 Aug 2021

Patient laments on not getting the COVID-19 vaccine

Saul Torres considers himself lucky to be alive after contracting COVID-19 and suffering from a rare neurological condition.

10 Aug 2021

New platform can quickly identify common mutations on the SARS-CoV-2 virus

Researchers at the University of Colorado Boulder have developed a platform which can quickly identify common mutations on the SARS-CoV-2 virus that allow it to escape antibodies and infect cells.

10 Aug 2021

Beige fat cells mediate subcutaneous fat's brain protection from dementia

Beige is considered a calming paint color, and scientists have new evidence that beige fat has a similar impact on the brain, bringing down the inflammation associated with the more common white fat and providing protection from dementia.

10 Aug 2021

Pilot study assesses antibody response to third COVID-19 vaccine dose in kidney transplant recipients

A pilot study has begun to assess the antibody response to a third dose of an authorized COVID-19 mRNA vaccine in kidney transplant recipients who did not respond to two doses of the Moderna or Pfizer-BioNTech COVID-19 vaccine.

10 Aug 2021

Flavonoid-based inhibitors targeting SARS-CoV 3CL protease for the treatment of SARS-CoV-2 infection

A new study has explored a series of potential flavonoid inhibitors targeting 3CL protease of SARS-CoV.

9 Aug 2021

Research finds disruption of flight-or-fight response in healthy young people diagnosed with COVID-19

New research published in The Journal of Physiology found that otherwise healthy young people diagnosed with COVID-19, regardless of their symptom severity, have problems with their nervous system when compared with healthy control subjects.

9 Aug 2021

Afrocentric health-promotion approach can help increase vaccination rates among Black people

To increase vaccination rates among Black people who are at high risk of COVID-19, employing an Afrocentric health-promotion approach that is centered on respecting patients' values and perspectives can help.

9 Aug 2021

Computational study identifies key areas of the SARS-CoV-2 genome prone to mutation

By retrieving 329,942 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) records from the GISAID database, researchers from a software company in Cambridge described genetic variability of SARS-CoV-2 in order to inform further studies. Their findings are currently available on the bioRxiv* preprint server while it undergoes peer review.

9 Aug 2021

New insight into impact of SARS-CoV-2 mutations on receptor binding

A recent study by Canadian researchers, currently available on the bioRxiv* preprint server, contributes to the growing body of literature on emerging variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by appraising the impact of single mutations on their overall antigenicity and binding affinity for the angiotensin-converting enzyme 2 (ACE2) receptor.

9 Aug 2021

Long COVID may be due to persistent immune disturbances

A new study discusses abnormalities in the immune response following COVID-19 in samples collected from patients who have recovered from COVID-19.

8 Aug 2021

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

New study offers suggestions for keeping classrooms safe during the Covid-19 pandemic

COVID-19 risks likely to shift from older adults to younger children

Breakthrough SARS-CoV-2 infections in patients with systemic rheumatic diseases

Socioeconomic privilege and political ideology correlate to racial disparities in COVID-19 vaccination

UC San Diego’s wastewater surveillance system enables early detection of most COVID-19 cases

Researchers employ artificial intelligence models for image-based detection of COVID-19

Plant-based virus-like particle vaccine induces durable immune response against SARS-CoV-2 variants

Both mRNA vaccines protect against symptomatic disease with SARS-CoV-2 Delta variant

High alcohol consumption increases risk of SARS-CoV-2 infection, finds US student study

Natural vs. vaccine-induced COVID-19 immunity

Patient laments on not getting the COVID-19 vaccine

New platform can quickly identify common mutations on the SARS-CoV-2 virus

Beige fat cells mediate subcutaneous fat's brain protection from dementia

Pilot study assesses antibody response to third COVID-19 vaccine dose in kidney transplant recipients

Flavonoid-based inhibitors targeting SARS-CoV 3CL protease for the treatment of SARS-CoV-2 infection

Research finds disruption of flight-or-fight response in healthy young people diagnosed with COVID-19

Afrocentric health-promotion approach can help increase vaccination rates among Black people

Computational study identifies key areas of the SARS-CoV-2 genome prone to mutation

New insight into impact of SARS-CoV-2 mutations on receptor binding

Long COVID may be due to persistent immune disturbances

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in